Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

246.46
Delayed Data
As of Jun 23
 -0.65 / -0.26%
Today’s Change
184.50
Today|||52-Week Range
261.27
+17.36%
Year-to-Date
Top Stock Reports for Oracle, Allergan & Abbott
Jun 23 / Zacks.com - Paid Partner Content
5 Reasons Why You Should Invest in AstraZeneca (AZN) in 2017
Jun 20 / Zacks.com - Paid Partner Content
My Trading and Investing Activity in Thursday's Session
Jun 23 / TheStreet.com - Paid Partner Content
Still Lovin' Allergan
Jun 20 / TheStreet.com - Paid Partner Content
The Long and Short of It
Jun 22 / TheStreet.com - Paid Partner Content
Global pharma sales forecasts cut amid pricing pressures
Jun 20 / FT.com - Paid Partner Content
Getting Ever Smaller in Allergan
Jun 22 / TheStreet.com - Paid Partner Content
Carl Icahn Buys Welbilt Inc, Sells Federal-Mogul Holdings Corp, Nuance Communications...
Jun 19 / GuruFocus News - Paid Partner Content
Putting More Allergan Profit in My Pocket
Jun 22 / TheStreet.com - Paid Partner Content
Allergan Is Putting the Bull Back in Charge
Jun 19 / TheStreet.com - Paid Partner Content
Pocketing Some Allergan Profit
Jun 22 / TheStreet.com - Paid Partner Content
AstraZeneca faces up to its year of living dangerously
Jun 11 / FT.com - Paid Partner Content
The Market Advance Narrows
Jun 22 / TheStreet.com - Paid Partner Content
Nuns target Google parent over spending on political lobbying
Jun 10 / FT.com - Paid Partner Content
FDA Commisoner Takes on Big Pharma
Jun 21 / TheStreet.com - Paid Partner Content
Ohio blames drugmakers for fueling opioid crisis
Jun 01 / CNNMoney.com
Time Frames and Market Views -- Selling Some Allergan
Jun 20 / TheStreet.com - Paid Partner Content
Ohio sues drugmakers over US opioid addiction crisis
May 31 / FT.com - Paid Partner Content